Abstract:507 Background: Patients with metastatic nonseminomatous germ cell tumours (NSGCTs) are treated with cisplatin-based chemotherapy, followed by postchemotherapy retroperitoneal lymph node dissection (pcRPLND) for patients with residual nodal masses >1 cm. However, 40–50% of patients who undergo pcRPLND are found to have fibrosis/necrotic tissue alone, which may result in overtreatment. Previous prediction models were based on a single method. We hypothesized that a radiomics-based model combined with serum micro-RNAs (miRNAs) including miR371 and miR375 could exhibit better prediction performance in histopathological presence of visible germ cell tumor, teratoma, and fibrosis/necrotic residual retroperitoneal masses. Methods: A retrospective review of 105 patients with 145 residual retroperitoneal masses undergoing pcRPLND for metastatic NSGCTs was performed to develop a prediction model. The dataset was split into separate training cohorts for model construction and validation cohorts for internal validation. On contrast-enhanced axial computed tomography images, 145 corresponding regions-of-interest (ROIs) of residual masses were segmented and 1130 radiomic features per ROI were extracted. After stepwise feature reduction based on reproducibility, variable importance, and correlation analyses, a logistic regression model was established on the selected most important features. Serum miRNA were used to optimize the classifier. The area under receiver operating characteristics curve (AUC), calibration curve, and decision-curve analyses (DCAs) were used to evaluated the prediction model. Results: The trained machine learning model achieved an AUC of 0.772 (95% CI: 0.670-0.875) in the training cohort and 0.764 (95% CI: 0.589-0.938) in the validation cohort. When serum miR371 and miR375 were added to the radiomics signature, the AUC of training cohort was improved to 0.900 (95% CI: 0.826-0.973), and the AUC of validation cohort was improved to 0.939 (95% CI: 0.847-1.000). Nomogram including radiomics score (Radscore) and miRNA was also performed, and the calibration curve analysis and the DCAs confirmed the agreement between prediction and observation and the clinical utility of the radiomics-miRNA prediction model respectively. Conclusions: Radiomics-miRNAs integrated model represents a novel tools for improved prediction of the histopathology of residual retroperitoneal masses in metastatic NSGCTs, aiming at reducing overtreatment. External validation and prospective datasets are needed to further validate this model.

A novel radiomics-miRNAs integrated model to predict the histopathology of residual retroperitoneal masses in metastatic nonseminomatous germ cell tumors.

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection

Building CT Radiomics-Based Models for Preoperatively Predicting Malignant Potential and Mitotic Count of Gastrointestinal Stromal Tumors

CT Radiomics and Clinical Feature Model to Predict Lymph Node Metastases in Early-Stage Testicular Cancer

Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma

Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach

Development and Internal Validation of a Preoperative Prediction Model for Sentinel Lymph Node Status in Breast Cancer: Combining Radiomics Signature and Clinical Factors

Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method

[Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer]

A radiomics and genomics-derived model for predicting metastasis and prognosis in colorectal cancer

Radiomics Based on Nomogram Predict Pelvic Lymphnode Metastasis in Early-Stage Cervical Cancer

Development of a Prediction Model for Gross Residual in High-Grade Serous Ovarian Cancer by Combining Preoperative Assessments of Abdominal and Pelvic Metastases and Multiparametric MRI

Evaluating peritumoral and intratumoral radiomics signatures for predicting lymph node metastasis in surgically resectable non-small cell lung cancer

Machine Learning-Based Prediction of Pathological Responses and Prognosis After Neoadjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Retrospective Study

MRI-based Radiomics Model for Preoperative Prediction of Lateral Pelvic Lymph Node Metastasis in Locally Advanced Rectal Cancer

Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer

Development and Validation of a Radiogenomics Model to Predict Axillary Lymph Node Metastasis in Breast Cancer Integrating MRI with Transcriptome Data: A Multicohort Study.

The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer

Machine Learning Radiomics-Based Prediction of Non-sentinel Lymph Node Metastasis in Chinese Breast Cancer Patients with 1-2 Positive Sentinel Lymph Nodes: A Multicenter Study

A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer